Evogene (EVGN)

1.350
+0.040(+3.06%)
  • Volume:
    293,864
  • Bid/Ask:
    0.000/0.000
  • Day's Range:
    1.230 - 1.380

EVGN Overview

Prev. Close
1.31
Day's Range
1.23-1.38
Revenue
970K
Open
1.28
52 wk Range
1.15-10.21
EPS
-0.75
Volume
293,864
Market Cap
56.4M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
330,480
P/E Ratio
-
Beta
1.31
1-Year Change
-78.63%
Shares Outstanding
41,164,424
Next Earnings Date
Mar 02, 2022
What is your sentiment on Evogene?
or
Vote to see community's results!

Evogene Company Profile

Employees
131
Market
Israel

Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through big data and artificial intelligence, designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules, and genetic elements. The company operates through three segments: Agriculture, Human Health, and Industrial Applications. The Agriculture segment develops seed traits, ag-chemical products, and ag-biological products to enhance plant performance. Its products focus on various crops, such as corn, soybean, wheat, rice, and cotton. The Industrial Applications segment develops enhanced castor bean seeds to serve as a feedstock source for other industrial uses. The Human Health segment discovers and develops human microbiome-based therapeutics for the treatment of immuno-oncology, GI related disorders, and antimicrobial resistance organisms. The company also provides medical cannabis products. It operates in the United States, Israel, Brazil, and internationally. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer; and through its subsidiary, Canonic Ltd., has a collaboration agreement with Cannbit Ltd., a subsidiary of Tikun Olam-Cannbit Ltd. for the development of novel medical cannabis products. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyNeutralSellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyBuyStrong SellStrong Sell
  • Target price 10$ within a month..
    0
    • On what basis? Your will?
      1
    • its 3.36 and over a month..
      0
    • it's not happened
      0
  • Just one more regular day..Company with a HUGE potential..
    0
    • we need this to 5x this year
      0
  • I was looking since 5 buck. might get it now
    0
    • I have drained all my bank accounts and even my credit card and student loans to hyper growth stocks. livin on the edge
      0
    • Good luck on it man
      0
    • currently 90% up in my whole portfolio in the past 3mo
      0
  • to the moon
    0
    • What are the thoughts on this?
      0
      • 🚀🚀🚀🚀🚀🚀
        0
        • Remember guys price target of 9$..
          1
          • Who set this target?
            0
          • probably citron
            0
        • will finish green today..
          0
          • +15% by the end of tge day..
            0
            • Jump in guys. Cantor fitzgeralt gave 9$ target price.https://m.marketscreener.com/quote/stock/EVOGENE-LTD-56536833/news/Cantor-Fitzgerald-Starts-Evogene-at-Overweight-With-9-Price-Target-31909026/
              0
              • Surpised to see no hype out here for EVGN.
                0
                • If it will ever go on the radar and if the hype factor will still be there as for other stock right now, it will skyrocket to 15 in no time
                  0
              • diluition
                0
                • Going to ***up, plantfuel! Is in the Ark portfolio now.
                  1
                  • I’m in from 2.1 very bullish on this one
                    0
                Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.